General discussion, page-14099

Evidence emerging from the pre eminent research facilities globally are clearly indicating the inflammatory response that is the root cause of long Covid......it is no longer speculation.

https://www.forbes.com/sites/williamhaseltine/2022/01/25/new-clues-to-long-covid-prolonged-inflammatory-response/?sh=32d029c7765c

those institutions include John Hopkins,

plenty more available on the web to fact check these findings

Should IHL 675A exhibit safety and efficacy in its trial performance outcomes it may well receive fast track approval status
from the FDA - why?
there is currently no standard of care / approved medication to treat this indication or the associated conditions that are emerging under the cloak of long covid ....that of course predominantly include mild to chronic heart inflammation in a high percentage of those suffering the ongoing long covid indication.

FDA already indicate this could be a multi indication drug candidate -long covid is now also potentially within that treatment spectrum

glah